Otonomy reports positive Phase Ib data of OTO-201 in children undergoing ear tube placement surgery

Clinical stage biopharmaceutical company Otonomy has reported positive data from a Phase Ib study of OTO-201, a sustained-release otic formulation of ciprofloxacin, in paediatric patients undergoing tympanostomy tube placement (TTP) surgery.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news